- Supplier site
- Group of sites (click to zoom)
Scientist.com supplier network (site locations)
Research supplier
i3 Consult
i3 Consult is listed as a small consultant research supplier in the Scientist.com network, with 1 site in 1 country.
View i3 Consult on Scientist.com
Email me this page as a PDF
Sign in to Scientist.com to open this supplier in your organization's marketplace.
Search companies, drugs, suppliers and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.
Sites
1
Countries
1
Services
What this research supplier says it provides, as listed in the Scientist.com network.
Type of company: Small consultant
Chemistry, Manufacturing and Controls (CMC)
- Chemistry, Manufacturing and Controls (CMC) Request Chemistry, Manufacturing and Controls services
Clinical Consulting
- Clinical Study Reporting (CSR) Report results of clinical trials to regulatory agencies. This includes participant flow, baseline characteristics, outcome measures, statistical analyses, and adverse events.
- Study Budgeting Consulting Request for Consulting Services
Clinical Trials
- Clinical Trial Risk Management Plan that maintains treatment quality throughout lifecycle and improve decision making.
- Prospective Explorative Studies Conduct a prospective exploratory study to assess the safety and efficacy of a test drug during clinical trials.
- Study/Site Feasibility Study Explore and test study practicality.
- Trial Insights: Clinical Trials Intelligence Dashboard Trial Insights is the industry’s first digital research reporting dashboard made specifically to track ongoing clinical trials, observational, diagnostic and medical device studies. The solution aggregates and curates...
Commercial Consulting
- Portfolio Management Manage a portfolio of projects in early-stage drug discovery and provide factors that determine the success of the proposed portfolio.
Drug Development
- Chemistry, Manufacturing and Controls (CMC) Consulting Consultant services related to the development of pharmaceutical and biopharmaceutical drug products that are consistently effective, safe and high quality for consumers.
- Chemoinformatics Consulting The use of computer and informational techniques applied to a range of problems in the field of chemistry.
- Consulting Services Work with consultants who provide expert advice in various areas of research and technology.
- Large Molecule Drug Development Consulting Develop large molecule drugs and complex biologics that have a therapeutic effect.
- Medicinal Chemistry Consulting Apply chemistry training to the process of synthesizing new pharmaceuticals.
- Small Molecule Drug Development Consulting Request consulting services related to small molecule development.
Show all 7 in Drug Development
- Target Validation Consulting Help to demonstrate that modification of target activity has potential therapeutic benefits.
Show all 60 services
HEOR
- Clinical Outcomes Measures patient's symptoms, mental, or physical effects of a disease or condition on how the patient functions, recorded by practitioner, provider, or instrument (not by patient).
- Comparative Effectiveness The generation and synthesis of evidence that compares the benefits and harms of alternative methods to prevent, diagnose, treat, and monitor a clinical condition or to improve the delivery of care.
- Cost Benefit Analysis Economic evaluation in which costs and benefits (outcomes) are expressed in monetary units, to determine if the benefits of an intervention outweigh the costs.
- Cost Effectiveness Analysis Compare alternative treatments that lead to similar health outcomes.
- Decision Analytic Modeling Assess effects, costs and economic outcomes of treatment. These include cost-effectiveness models and budget impact models.
- Health Economics and Outcomes Research (HEOR) Evaluate data collected during drug development to maximize the value of a therapeutic product.
Show all 9 in HEOR
- Patient Treatment Patterns Assessment of treatment processes and patterns within clinical practice.
- Resource Utilization Descriptive and/or analytical review of a treatment that investigate the marketing, distribution, prescription, and use of drugs in populations. Endpoints to be assessed are the medical, social, and economic outcomes.
- Therapy Switch Insight into the reasoning of patients switching treatments and the outcomes of the switch.
Market Access
- Emerging Market Opportunities Analyze risks and opportunities in new markets and ensure patients have timely and continued access to new treatments.
- Health Technology Assessment Submission (HTA Submission) Analyze the medical, social, ethical, humanistic, and economic considerations of a drug, medical device, or clinical procedures. Submissions are sent to regulatory agencies with different requirements that govern...
- Life Science Reports Life Science reports
- Market Access Materials Find general strategies and methods used to market a pharmaceutical product or device.
- Market Research & Business Intelligence Run market feasibility studies, establish customer needs, improve product performance and analyze competition.
- Marketing and Commercialization Identify, promote and prove the value of a particular drug to key stakeholders.
Show all 8 in Market Access
- Pharmaceutical Reports Pharmaceutical Reports
- Pricing Strategy Develop value story tailored to a payer audience that will determine the appropriate price for treatment.
Medical Communications
- Communication Plan Communications plan enables organizations and corporations to effectively deliver information to appropriate stakeholders and customers.
- Distribution Strategy & Channel Recommendations Developing plans for how and where medical content (e.g., publications, training, MOA videos) will be efficiently delivered to the target healthcare audience.
- Gap Analysis Compare the actual performance of an organization or corporation with potential or desired performance, as ways to effectively analyze resource management or allocation.
- Landscape Analysis Find a cohesive and consistent view of your main organization. Develop initiatives in analyzed areas of operations and analyze chosen key aspects of them.
- Market & Competitor Analyses Evaluating the current therapeutic landscape, identifying unmet needs, and assessing the scientific positioning and data of competitor products.
- Medical Writing and Editing/Manuscript Development Communicate scientific, technical and health-related information to a range of audiences.
Show all 11 in Medical Communications
- Payer Directed Communication Tools (other than Dossiers) Request services related to payer directed communication tools.
- Publications Plan Development & Management Strategic planning and oversight of all research dissemination activities, including outlining target journals, timelines, authors, and compliance for clinical data publications.
- Scientific Platform Develop a rigorous approach to creating a core story (grounded in the scientific literature) for a product. This involves identifying core concepts that address disease states, clinical needs, and product-related...
- Strategic Medical Communication Development & Planning High-level planning to define the core scientific messages and the tactical strategy needed to effectively convey clinical data to key stakeholders over time.
- Target Product Profile (TPP) A sponsor prepared document which summarizes the drug development program that is described in terms of the labelling concepts. This profile is a communication method used between the FDA and sponsor which can be used...
Medical/Commercial
- Health & Pharmacoeconomics Identify, measure and compare the cost-benefit ratio of products and services.
- Life Cycle Assessment (LCA) Analyze the lifecycles of the products and services with regard to their environmental impacts.
Old Category HEOR, RWE, Market Access
- Health Technology Assessment Submission (HTA Submission) (DUPLICATE) Conduct a multidisciplinary process that determines the value of a health technology through different points in its lifecycle.
- Non-Interventional Studies Examine different aspects of drug usage, including efficacy and safety, under real-life conditions.
- RWE/RWD Enriched Studies Combine different methodologies (retrospective, prospective, registries, chart or claims review, electronic medical/health records) to gain insights into real world patient behavior or drug use.
Real World Evidence & Data
- Exploratory Study Explore study design, outcomes, data-collection method, and selection of population for a topic that needs more research information.
- Pragmatic Clinical Trial Randomized trial comparing two or more treatments in a real world setting. The trial possesses minimal exclusion criteria and closely follows the procedures of the clinical practice in order to mirror clinical care...
- Real World Evidence (RWE) Studies Studies (prospective or retrospective) utilizing data obtained from "real world settings" , and is outside the tight controls of a clinical trial design.
- Real-World Data Acquire real-world data from patients' electronic medical records including clinical information generated during the course of healthcare.
- Real-World Evidence Acquire clinical data from patients' medical records to analyze trends and the frequency of occurrence of different medical conditions.
- RWE/HEOR/Market Access Safety Surveillance Monitor safety of treatment and determine methods to identify adverse events early
Show all 7 in Real World Evidence & Data
- RWE/RWD Observational Research Research method for documenting clinical, economic, and or humanistic outcomes of actual medical practice absent the constraints of a more formal experimental design. See also Pragmatic Clinical Trials.
Regulatory Affairs
- Life Cycle Management Plan and strategy of the data collection and information throughout the different phases of product development (portfolio assessment, pre-clinical trials, clinical trials, pre-authorization, post-authorization, and RWE)
- Period Benefit Risk Evaluation Report (PBRER) Preparation of safety reports to report adverse events that occurred during a specified time period. Evaluate if safety profile of treatment has changed since last report
- Post Authorization Safety Study (PASS) Evaluate the safety, benefit-risk profile, and risk management of a treatment. These studies are specifically asked for by European Medicines Agency (EMA) and they can be mandatory or voluntary.
- Risk Benefit Assessment Determine ratio of treatment risk to the potential benefits.
Other services
- Observational Research Gain valuable insights into the association between a drug treatment and its outcomes such as long-term effectiveness and safety.
- Website
- i3consult.com
Where it operates
Sites by country, with the cities in each.
-
France 1 site
Work with i3 Consult on Scientist.com
For prices, more details, or to contact i3 Consult, visit Scientist.com.
Sign in to Scientist.com to open this supplier in your organization's marketplace.